European CHMP recommends license extension and new strength of Trimbow (beclometasone / formoterol / glycopyrronium bromide)

The license extension is for maintenance treatment of asthma in adults not adequately controlled with a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. The new strength is 172/5/9mcg.

Source:

European Medicines Agency